Treace Medical Concepts Future Growth
Future criteria checks 0/6
Treace Medical Concepts is forecast to grow earnings and revenue by 13.5% and 8.2% per annum respectively. EPS is expected to grow by 14.7% per annum. Return on equity is forecast to be -47.7% in 3 years.
Key information
13.5%
Earnings growth rate
14.7%
EPS growth rate
| Medical Equipment earnings growth | 17.1% |
| Revenue growth rate | 8.2% |
| Future return on equity | -47.7% |
| Analyst coverage | Good |
| Last updated | 08 Nov 2024 |
Recent future growth updates
Recent updates
Is Treace Medical Concepts (NASDAQ:TMCI) Using Debt In A Risky Way?
Oct 26
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Screens Well But There Might Be A Catch
Aug 02Treace Medical Concepts (NASDAQ:TMCI) Has Debt But No Earnings; Should You Worry?
Jun 28Treace Medical Concepts: Facing Increasing Competitive Pressure
Jun 14Market Still Lacking Some Conviction On Treace Medical Concepts, Inc. (NASDAQ:TMCI)
Apr 05Does Treace Medical Concepts (NASDAQ:TMCI) Have A Healthy Balance Sheet?
Feb 09Why Investors Shouldn't Be Surprised By Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) 31% Share Price Surge
Jan 04Market Cool On Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) Revenues Pushing Shares 46% Lower
Nov 11Analysts Are Updating Their Treace Medical Concepts, Inc. (NASDAQ:TMCI) Estimates After Its Second-Quarter Results
Aug 13Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 246 | -43 | -13 | -11 | 6 |
| 12/31/2025 | 225 | -48 | -14 | -13 | 6 |
| 12/31/2024 | 208 | -57 | -36 | -22 | 6 |
| 9/30/2024 | 203 | -62 | -43 | -32 | N/A |
| 6/30/2024 | 199 | -64 | -42 | -30 | N/A |
| 3/31/2024 | 196 | -55 | -38 | -25 | N/A |
| 12/31/2023 | 187 | -50 | -46 | -35 | N/A |
| 9/30/2023 | 175 | -48 | -52 | -40 | N/A |
| 6/30/2023 | 167 | -42 | -52 | -38 | N/A |
| 3/31/2023 | 155 | -47 | -56 | -41 | N/A |
| 12/31/2022 | 142 | -43 | -45 | -31 | N/A |
| 9/30/2022 | 126 | -45 | -42 | -29 | N/A |
| 6/30/2022 | 114 | -39 | -39 | -31 | N/A |
| 3/31/2022 | 105 | -27 | -28 | -24 | N/A |
| 12/31/2021 | 94 | -21 | -20 | -17 | N/A |
| 9/30/2021 | 85 | -12 | -13 | -11 | N/A |
| 6/30/2021 | 78 | -8 | -7 | -6 | N/A |
| 3/31/2021 | 65 | -5 | -5 | -4 | N/A |
| 12/31/2020 | 57 | -4 | -6 | -4 | N/A |
| 12/31/2019 | 39 | -5 | -9 | -8 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TMCI is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: TMCI is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: TMCI is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: TMCI's revenue (8.2% per year) is forecast to grow slower than the US market (9% per year).
High Growth Revenue: TMCI's revenue (8.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: TMCI is forecast to be unprofitable in 3 years.